ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z
  • Abstract Number: 1609
    Lack of Association Between ZHX2, Lepr, Gckr and ASCL1 and Carotid Intima-Media Thickness, Carotid Plaques and Cardiovascular Disease in Patients with Rheumatoid Arthritis
  • Abstract Number: 1952
    Lack of Association of a 6.7 Kbp Deletion of LILRA3 with Giant Cell Arteritis
  • Abstract Number: 1659
    Lack of Effect of Reduced Folic Acid Supplementation on Disease Activity in RA
  • Abstract Number: 1615
    Lack of Replication of the Association Between Anti-Citrullinated Fibrinogen and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
  • Abstract Number: 336
    Lack of Uniform Diagnostic Criteria for Erosive OA: A Systematic Review
  • Abstract Number: 1991
    Large Vessel Involvement By IgG4-Related Disease
  • Abstract Number: 2979
    Laser Speckled Imaging and Videomicroscopy Assessment of Sublingual Perfusion in Systemic Sclerosis and Healthy Controls
  • Abstract Number: 733
    Late Onset Systemic Lupus Erythematosus: A Different Disease Subset?
  • Abstract Number: 894
    Late-Onset IgA Vasculitis in Adult Patients Exhibits Distinct Clinical Characteristics and Outcomes
  • Abstract Number: 2903
    Late-Onset Neutropenia Following Rituximab Treatment in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2790
    Leflunomide/Hydroxychoroquine Combination Treatment Additively Inhibits T Cell Receptor/Toll-like Receptor 9-Triggered Th1 and Th17 Cytokine Secretion 
  • Abstract Number: 1821
    Leptin, Adiponectin, and Resistin As Serum Markers of Fatigue in Systemic Lupus Erythematosus: A Pilot Study
  • Abstract Number: 2353
    Lesinurad and Febuxostat Combination Therapy: Analysis of Treatment Based on Patient Baseline Renal Function
  • Abstract Number: 2113
    Lesinurad, a Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout
  • Abstract Number: 2596
    Less Musculoskeletal Ultrasound Power Doppler Activity Seen in Obese Rheumatoid Arthritis
  • Abstract Number: 1085
    Levamisole Triggers Neutrophil Extracellular Trap Formation through Muscarinic Receptors in Patients with Drug-Induced Vasculitis
  • Abstract Number: 334
    Lifetime Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project
  • Abstract Number: 135
    Limitations of Treat-to-Target in Rheumatoid Arthritis: Joint Damage Appears As Severe As Inflammation in Contemporary Care at One Site
  • Abstract Number: 1508
    Lipid Target Achievement Among Patients with Recent-Onset Rheumatoid Arthritis during the First Six Years of Follow-up: Results from a French Multicenter Cohort of Early Arthritis
  • Abstract Number: 1788
    Lipoprotein Subfractions and Cardiovascular Disease in Systemic Lupus Erythematosus
  • Abstract Number: 2336
    Literature Review of Patient Reported Outcome and Health Related Quality of Life Measures for Biologic Therapies in the Management of Psoriatic Arthritis and Ankylosing Spondylitis
  • Abstract Number: 2152
    Long Noncoding H19X Is a Key Mediator of Tgf-Beta Induced Pro-Fibrotic Effects in the Pathogenesis of Systemic Sclerosis and Other Fibrotic Diseases
  • Abstract Number: 3041
    Long Term Biological Therapy in Uveitis Refractory Due to Behçet’s Disease. Multicenter Study of 165 Patients. 
  • Abstract Number: 2049
    Long Term Effectiveness of Herpes Zoster Vaccine Among Patients with Autoimmune and Inflammatory Diseases
  • Abstract Number: 406
    Long Term Follow up of Inner City Pediatric Patients with Lupus Nephritis
  • Abstract Number: 3069
    Long Term Follow-up Results of Endovascular Repair in the Management of Arterial Stenosis Caused By Takayasu Arteritis
  • Abstract Number: 1396
    Long Term Outcome of Neurosarcoidosis
  • Abstract Number: 2195
    Long Term Outcome of Primary Antiphospholipid Syndrome Patients: A Multicenter Study
  • Abstract Number: 1701
    Long Term Outcome of Total Hip Replacement in Patients with Ankylosing Spondylitis
  • Abstract Number: 2840
    Long-Term (104 Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
  • Abstract Number: 2843
    Long-Term (156-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)
  • Abstract Number: 619
    Long-Term Adverse Events after Daily Concomitant Treatment with 10mg Prednisone in the 2-Year Computer Assisted Management in Early Rheumatoid Arthritis Trial-II
  • Abstract Number: 1446
    Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry
  • Abstract Number: 2885
    Long-Term Effects of Etanercept on Patient-Reported Outcomes in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Results of a Phase III Study
  • Abstract Number: 939
    Long-Term Efficacy and Safety of Canakinumab in Active Hyperimmunoglobulinemia D with Periodic Fever Syndrome
  • Abstract Number: 938
    Long-Term Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF Receptor-Associated Periodic Syndrome
  • Abstract Number: 2427
    Long-Term Efficacy and Safety of Mycophenolate Mofetil in Childhood Primary Central Nervous System Vasculitis
  • Abstract Number: 1351
    Long-Term Efficacy of Latent Tuberculosis Infection Screening in Juvenile Idiopathic Arthritis Patients Prior to Anti-TNF Treatment in an Endemic Area
  • Abstract Number: 596
    Long-Term High Remission Rates and Distinct Trajectories of Disease Activity Following the Implementation of Treat-to-Target in Early Rheumatoid Arthritis
  • Abstract Number: 2835
    Long-Term Improvements with Certolizumab Pegol in Joints and Extra-Articular Manifestations of Psoriatic Arthritis in Patients with and without Prior Anti-TNF Exposure
  • Abstract Number: 276
    Long-Term Outcome in Mixed Connective Tissue Disease
  • Abstract Number: 1816
    Long-Term Outcome of Tacrolimus Therapy As a Maintenance Strategy in Patients with Lupus Nephritis
  • Abstract Number: 2046
    Long-Term Outcomes in Cardiac Neonatal Lupus and Associated Risk Factors for Morbidity
  • Abstract Number: 404
    Long-Term Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 780
    Long-Term Prognosis and Factors Associated with Damage Accrual in Japanese Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1633
    Long-Term Radiographic and Patient-Reported Outcomes Based on Clinical Disease Activity Index Responses with Tofacitinib at 6 Months
  • Abstract Number: 2765
    Long-Term Retention Rate of First Biologics in Patients of Age over 75 Years with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
  • Abstract Number: 3111
    Long-term Safety and Efficacy of Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-α (GM–CSFR-α) Monoclonal Antibody, in Patients with Rheumatoid Arthritis (RA)
  • Abstract Number: 1649
    Long-Term Safety and Efficacy of Olokizumab in Patients with Moderate-to-Severe Rheumatoid Arthritis Who Have Previously Failed Anti-TNF Treatment
  • Abstract Number: 1795
    Long-Term Safety and Efficacy of Tacrolimus for Lupus Nephritis Patients in Real World Setting -Results from 5 Year Interim Analysis of Post Marketing Surveillance of 1376 Patients in Japan-
  • Abstract Number: 2431
    Long-Term Safety of Adalimumab Treatment in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis and Enthesitis-Related Arthritis
  • Abstract Number: 2759
    Long-Term Survival of Biological Therapy in Rheumatoid Arthritis Elderly Patients in Clinical Practice
  • Abstract Number: 1977
    Long-Term Survival of Methotrexate in Giant Cell Arteritis Patients in Clinical Practice
  • Abstract Number: 2854
    Long-Term Tolerability and Efficacy of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results from the Open-Label Extension of a Randomized, Double-Blind Study
  • Abstract Number: 1225
    Long-Term Use of Biological Therapy and Discontinuation Rates in Rheumatoid Arthritis – Real World Patient Data
  • Abstract Number: 891
    Long-Term Use of Rituximab for Eosinophilic Granulomatosis with Polyangiitis
  • Abstract Number: 2864
    Long-Term Work Productivity Improvement Associated with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Analysis of 3 Phase 3 Studies
  • Abstract Number: 2942
    Longitudinal Analyses of Progression of Brain Athrophy in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 2978
    Longitudinal Assessment of Gastrointestinal Symptoms in the Prospective Registry of Early Systemic Sclerosis Cohort
  • Abstract Number: 744
    Longitudinal Assessment of Th1 and Th2 Cytokines: A Comparison Between Adult-Onset and Childhood-Onset Systemic Lupus Erythematous
  • Abstract Number: 397
    Longitudinal Observation of Psychological Factors and Health-Related Quality of Life in Childhood-Onset Lupus
  • Abstract Number: 113
    Longitudinal, Incremental Direct Medical Costs of Giant Cell Arteritis for the First Five Years Following Diagnosis: A General Population-Based Cohort Study
  • Abstract Number: 2524
    Longterm Follow-up of Children Born to Mothers with Chronic Arthritides and Exposed to Anti-TNF Alfa Agents during Pregancy and Breastfeeding: A Case-Control Study
  • Abstract Number: 2774
    Longterm Outcome of Patients Switched from Iv to Sc Formulation of Abatacept: A Monocentric Study
  • Abstract Number: 2203
    Loss of Wdfy3 Leads to Enhanced Osteoclastogenesis Via NF-κB Activation
  • Abstract Number: 352
    Low Bone Density Is Associated with Atherosclerotic Disease in Patients with Psoriatic Arthritis
  • Abstract Number: 2068
    Low Complement Is Associated with SLE Classification Criteria and Organ Damage
  • Abstract Number: 446
    Low Disease Activity at 12 Weeks and 24 Weeks Is Predictive of Normalized Health-Related Quality of Life in Methotrexate-Experienced Patients with Active Rheumatoid Arthritis Treated with Intravenous Golimumab Plus Methotrexate
  • Abstract Number: 2658
    Low Disease Activity Is Associated with Higher HDL and a Trend to Lower Insulin Resistance in Rheumatoid Arthritis Patients
  • Abstract Number: 2169
    Low Education Is Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project
  • Abstract Number: 1137
    Low Molecular Weight Polyphenol Harpagoside Inhibits IL-1β-Induced Expression of IL-6 By Blocking the Expression and Activity of c-Fos in Primary Human Osteoarthritis Chondrocytes
  • Abstract Number: 2933
    Low Prevalence of PCP in Hospitalized Patients with SLE: Review of a Clinical Database Warehouse
  • Abstract Number: 1270
    Low Socioeconomic Status As a Predictor of Long-Term Direct Medical Costs Following Diagnosis of Granulomatosus with Polyangiitis: A General Population-Based Cohort Study
  • Abstract Number: 85
    Low Socioeconomic Status, High Disability Rates, and  Increased Use of Health Care Resources in Fibromyalgia Patients Taking Narcotics
  • Abstract Number: 882
    Lung Damage in ANCA Associated Vasculitis Assessed By Vasculitis Damage Index: Recurrent Pulmonary Infections Have a Significant Contribution
  • Abstract Number: 814
    Lupus Drives Atherosclerosis through CD4+CXCR3+ T Cells and Plasmacytoid Dendritic Cells
  • Abstract Number: 2921
    Lupus Nephritis: An Exploration of Management Style
  • Abstract Number: 763
    Lupus-Related SNPs and Risk of Diffuse Large B-Cell Non-Hodgkin Lymphoma
  • Abstract Number: 1777
    Lymphocyte Depletion, Recovery and Efficacy in NZBWF1 Lupus Mice Following Continuous or Intermittent Dosing Regimen of Venetoclax (ABT-199), a Potent and Selective BCL-2 Inhibitor
  • Abstract Number: 869
    Lymphoma in Patients with Granulomatosis with Polyangiitis
  • Abstract Number: 2052
    Lymphoma in Patients with Rheumatoid Arthritis Treated with Biologic Drugs:  Long-Term Follow-up of Risks and Lymphoma Subtypes
  • Abstract Number: 815
    Lys63-Polyubiquitination By the E3 Ligase Casitas B-Lineage Lymphoma-b Modulates Peripheral Regulatory T Cell Tolerance in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1913
    Lysyl Oxidase Induces Fibrosis Via Upregulation of IL-6 and Serves As a Biomarker to Monitor Response to Therapy
Jump to:  View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.